These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 4145866)

  • 1. The relationship between blood levels of different forms of butaperazine and clinical response.
    Simpson GM; Lament R; Cooper TB; Lee JH; Bruce RB
    J Clin Pharmacol; 1973 Jul; 13(7):288-97. PubMed ID: 4145866
    [No Abstract]   [Full Text] [Related]  

  • 2. A comparative study of butaperazine, chlorpromazine and placebo in chronic schizophrenics.
    Keskiner A; Itil TM; Todt N
    Psychosomatics; 1970; 11(2):120-6. PubMed ID: 4394278
    [No Abstract]   [Full Text] [Related]  

  • 3. Relative efficacy of butaperazine and chlorpromazine in acute schizophrenia.
    Gershon S; Hekimian LJ; Burdock EI; Park S; Floyd A
    Curr Ther Res Clin Exp; 1970 Dec; 12(12):810-8. PubMed ID: 4396420
    [No Abstract]   [Full Text] [Related]  

  • 4. Butaperazine (Repoise).
    Med Lett Drugs Ther; 1968 Nov; 10(22):89-90. PubMed ID: 4389275
    [No Abstract]   [Full Text] [Related]  

  • 5. Piperacetazine in ambulatory chronic schizophrenic patients.
    Rada RT; Donlon PT
    Curr Ther Res Clin Exp; 1974 Feb; 16(2):124-9. PubMed ID: 4156665
    [No Abstract]   [Full Text] [Related]  

  • 6. Relationship of butaperazine blood levels to plasma prolactin in chronic schizophrenic patients.
    Smith RC; Tamminga CA; Crayton JW; Dekirmenjian H; Davis JM
    Psychopharmacology (Berl); 1979; 66(1):29-33. PubMed ID: 44374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of piperacetazine (Quide) injection in acute schizophrenics.
    Kiev A; Güclü B; Kulkarni AS
    Curr Ther Res Clin Exp; 1972 Jul; 14(7):376-80. PubMed ID: 4625517
    [No Abstract]   [Full Text] [Related]  

  • 8. Evaluation of Mesoridazine. (Serentil).
    JAMA; 1971 Apr; 216(2):313-4. PubMed ID: 5107916
    [No Abstract]   [Full Text] [Related]  

  • 9. The pharmacokinetics of butaperazine in serum.
    Davis JM; Janowsky DS; Sekerke HJ; Manier H; el-Yousef MK
    Adv Biochem Psychopharmacol; 1974; 9(0):433-43. PubMed ID: 4151767
    [No Abstract]   [Full Text] [Related]  

  • 10. Sensitivity to a phenothiazine (butaperazine).
    Simpson GM; Laska E
    Can Psychiatr Assoc J; 1968 Dec; 13(6):499-506. PubMed ID: 4387257
    [No Abstract]   [Full Text] [Related]  

  • 11. Neuroleptic drug levels and therapeutic response: preliminary observations with red blood cell bound butaperazine.
    Garver DL; Dekirmenjian H; Davis JM; Casper R; Ericksen S
    Am J Psychiatry; 1977 Mar; 134(3):304-7. PubMed ID: 14514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A controlled study of mesoridazine: an effective treatment for schizophrenia.
    McIndoo MV
    South Med J; 1971 May; 64(5):592-6. PubMed ID: 4929612
    [No Abstract]   [Full Text] [Related]  

  • 13. The differential response to parenteral chlorpromazine and mesoridazine in psychotic patients.
    Brauzer B; Goldstein BJ
    J Clin Pharmacol J New Drugs; 1970; 10(2):126-31. PubMed ID: 4906541
    [No Abstract]   [Full Text] [Related]  

  • 14. Butaperazine pharmacokinetics. Effect of dosage regimen on steady state blood levels.
    Cooper TB; Simpson GM; Haher EF; Bergner PE
    Arch Gen Psychiatry; 1975 Jul; 32(7):903-5. PubMed ID: 239664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relation of plasma prolactin to clinical response in schizophrenic patients.
    Gruen PG; Sachar EJ; Altman N; Langer G; Tabrizi MA; Halpern FS
    Arch Gen Psychiatry; 1978 Oct; 35(10):1222-7. PubMed ID: 29592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenothiazine levels in plasma and red blood cells. Their relationship to clinical improvement in schizophrenia.
    Casper R; Garver DL; Dekirmenjian H; Chang S; Davis JM
    Arch Gen Psychiatry; 1980 Mar; 37(3):301-5. PubMed ID: 6102458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of conjugated estrogens on plasma butaperazine levels.
    El-Yousef MK; Manier DH
    Psychopharmacologia; 1974; 39(1):39-41. PubMed ID: 4153665
    [No Abstract]   [Full Text] [Related]  

  • 18. Evaluation of a new antipsychotic agent. Butaperazine maleate (repoise maleate).
    JAMA; 1968 Dec; 206(10):2307-8. PubMed ID: 4386884
    [No Abstract]   [Full Text] [Related]  

  • 19. Plasma butaperazine levels in long-term chronic non-responding schizophrenics.
    Smith RC; Dekirmenjian H; Davis JM; Crayton J; Evans H
    Commun Psychopharmacol; 1977; 1(4):319-24. PubMed ID: 28201
    [No Abstract]   [Full Text] [Related]  

  • 20. Butaperazine in chronic schizophrenic patients: a doubled-blinf study.
    Brotman RK; Muzekari LH; Shanken PM
    Curr Ther Res Clin Exp; 1969 Jan; 11(1):5-8. PubMed ID: 4387485
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.